M. Palla6icini et al. / Tetrahedron: Asymmetry 13 (2002) 2277–2282
2281
0.1
M
NaClO4/CH3CN, 0.5 ml/min); 1H NMR
dichloromethane. Removal of the solvent from the
extract, previously dried over Na2SO4, gave a colour-
less oil, which was distilled under vacuum yielding
(S)-8 (2.27 g, 61.0%): [h]2D0=+3.8 (neat); the e.e. was
identical to that previously determined for the amine
liberated from a sample of the salt with (S)-2 and
(DMSO-d6) l 1.22 (s, 3H), 1.30 (s, 3H), 1.60 (d, 3H),
3.82 (dd, 1H), 4.02 (pseudo t, 1H), 4.20 (d, 2H), 4.33
(m, 1H), 5.20 (q, 1H), 7.44 (m, 5H), 7.82 (d, 1H),
7.88 (d, 1H), 7.97 (m, 4H), 8.13 (d, 1H), 8.28 (s, 1H).
The salt was decomposed by treatment with 2N
H2SO4 and ethyl acetate. The aqueous phase was sep-
arated, made alkaline with NaOH and extracted with
ethyl acetate. Removal of the solvent from the
extract, previously dried over Na2SO4, gave an oil,
which was distilled under vacuum yielding (R)-6 (1.70
g, 44%): [h]2D0=+53.5 (c 2, ethanol); the e.e. was iden-
tical to that previously determined for the amine lib-
1
benzoylated; H NMR (CDCl3) l 0.80–1.25 (m, 8 H),
0.98 (d, 3H), 1.55–1.78 (m, 5H), 2.60 (m, 1H). The
filtrate from the crystallization of (S)-2·(S)-8 was con-
centrated and the residual salt decomposed in the
same way as described for (S)-2·(S)-8 to afford the
R-enriched amine (5.0 g): [h]2D0=−1.4 (neat); e.e.:
42.0% (determined by HPLC of the corresponding
benzamide).
1
erated from a sample of the salt with (S)-2; H NMR
(CDCl3) l 1.58 (d, 3H), 1.72 (bs, 2H), 4.97 (q, 1H),
7.50 (m, 3H), 7.67 (d, 1H), 7.76 (d, 1H), 7.89 (d, 1H),
8.13 (d, 1H).
4.11. (S)-2-Butylamine hydrochloride, (S)-9
The acid (S)-2 (13.8 g, 41.8 mmol) and (RS)-2-butyl-
amine (3.06 g, 41.8 mmol) were combined in 2-
propanol (50 ml) at room temperature. The white
precipitate (7.28 g) was collected by filtration, rinsed
with cold 2-propanol, dried, and recrystallized from
ethanol (7 ml) at 0°C yielding the salt of (S)-2-butyl-
amine with (S)-2 (2.3 g, 27%): mp 106–107°C; e.e. of
(S)-2-butylamine: 77.9% (43.5% before the recrystal-
lization) (determined by HPLC of the corresponding
benzamides on a Chiralcel OB column; hexane/2-
propanol 95/5, 1.2 ml/min); 1H NMR (DMSO-d6) l
0.88 (t, 3H), 1.17 (d, 3H), 1.28 (s, 3H), 1.33 (s, 3H),
1.45 (m, 1H), 1.64 (m, 1H), 3.05 (m, 1H), 3.82
(pseudo t, 1H), 4.04 (pseudo t, 1H), 4.19 (d, 2H),
4.36 (m, 1H), 7.52 (m, 2H), 7.85–8.0 (m, 3H), 8.21 (s,
1H). The salt was decomposed by treatment with 10%
HCl and ethyl acetate. The aqueous phase was sepa-
rated, washed with ethyl acetate, and concentrated to
give (S)-9 (0.60 g, 26%) as a white solid: mp 145–
147°C; [h]3D7=−2.6 (c 1, ethanol); the e.e. was identi-
cal to that previously determined for the benzamide
of the amine liberated from a sample of the recrystal-
4.9. (S)-1-Phenyl-2-propylamine, (S)-7
The acid (S)-2 (5.01 g, 15.2 mmol) and (RS)-7 (2.05
g, 15.2 mmol) were combined in methanol (20 ml) at
room temperature. After cooling to 5°C, the white
precipitate of (S)-2·(S)-7 salt (2.72 g, 77%) was col-
lected by filtration and rinsed with cold methanol: mp
141–142°C; e.e. of (S)-7: 78.0% (determined by HPLC
of the corresponding benzamide on a Chiralcel-OB
1
column, hexane/2-propanol 9/1, 2 ml/min); H NMR
(DMSO-d6) l 1.08 (d, 3H), 1.24 (s, 3H), 1.30 (s, 3H),
2.62 (dd, 1H), 3.08 (dd, 1H), 3.37 (m, 1H), 3.80 (dd,
1H), 4.02 (pseudo t, 1H), 4.20 (d, 2H), 4.33 (m, 1H),
7.15–7.35 (m, 5H), 7.55 (m, 2H), 7.90–8.02 (m, 3H),
8.25 (s, 1H). The salt was decomposed by treatment
with 2N H2SO4 and ethyl acetate. The aqueous phase
was separated, made alkaline with NaOH, and
extracted with dichloromethane. Removal of the sol-
vent from the extract, previously dried over Na2SO4,
gave a colourless oil, which was distilled under vac-
uum yielding (S)-7 (0.72 g, 70%): [h]2D1=+25.4 (c 2.85,
methanol); [h]2D0=+30.5 (c 1.8, benzene); the e.e. was
identical to that previously determined for the amine
liberated from a sample of the salt with (S)-2 and
1
lized salt with (S)-2; H NMR (DMSO-d6) l 0.86 (t,
3H), 1.15 (d, 3H), 1.45 (m, 1H), 1.62 (m, 1H), 3.01
(m, 1H), 8.12 (bs, 3H).
1
benzoylated; H NMR (CDCl3) l 1.11 (d, 3H), 1.25
(bs, 2H), 2.50 (dd, 1H), 2.72 (dd, 1H), 3.16 (m, 1H),
7.15–7.33 (m, 5H).
Acknowledgements
4.10. (S)-1-Cyclohexylethylamine, (S)-8
The acid (S)-2 (19.33 g, 58.5 mmol) and (RS)-8 (7.44
g, 58.5 mmol) were combined in methanol (70 ml) at
room temperature. After cooling to 5°C, the white
precipitate of (S)-2·(S)-8 salt (8.26 g, 62%) was col-
lected by filtration and rinsed with cold methanol: mp
146–147°C; e.e. of (S)-8: 94.1% (determined by HPLC
of the corresponding benzamide on a Chiralcel-OD
column; hexane/2-propanol 9/1, 0.7 ml/min); 1H
NMR (DMSO-d6) l 0.85–1.80 (m, 11H), 1.10 (d, 3H),
1.28 (s, 3H), 1.33 (s, 3H), 2.94 (m, 1H), 3.82 (pseudo
t, 1H), 4.04 (pseudo t, 1H), 4.20 (d, 2H), 4.37 (m,
1H), 7.52 (m, 2H), 7.85–8.0 (m, 3H), 8.22 (s, 1H).
The salt was decomposed by treatment with 10% HCl
and ethyl acetate. The aqueous phase was separated,
made alkaline with NaOH, and extracted with
This work was supported by the Ministero dell’Uni-
versita` e della Ricerca Scientifica e Tecnologica of
Italy.
References
1. Pallavicini, M.; Valoti, E.; Villa, L.; Piccolo, O. Tetra-
hedron: Asymmetry 2001, 12, 2489.
2. Pallavicini, M.; Valoti, E.; Villa, L.; Piccolo, O. Tetra-
hedron: Asymmetry 1996, 7, 1117.
3. Pallavicini, M.; Valoti, E.; Villa, L.; Piccolo, O. Tetra-
hedron: Asymmetry 1997, 8, 1069.